Evaluation of Microglial Activation in ALS With [18F]PBR06 (Peripheral Benzodiazepine Receptor-06) PET
Status:
Completed
Trial end date:
2018-02-07
Target enrollment:
Participant gender:
Summary
The overall goal of this protocol is to evaluate microglial activation in the brain using
[18F]PBR06 in patients with amyotrophic lateral sclerosis (ALS).